Literature DB >> 21255858

Association of eNOS gene polymorphisms with renal disease in Caucasians with type 2 diabetes.

Kátia G Santos1, Daisy Crispim, Luís H Canani, Paula T Ferrugem, Jorge L Gross, Israel Roisenberg.   

Abstract

AIM: In this study we investigated if the -786T>C, the VNTR intron 4 a/b and the 894G>T (Glu298Asp) polymorphisms in the eNOS gene were associated with renal disease in 617 type 2 diabetic Caucasian-Brazilians. These polymorphisms were also examined in 100 Caucasian healthy blood donors.
METHODS: Genotyping of eNOS polymorphisms was performed by PCR or PCR-RFLP and haplotype frequencies were estimated using a Bayesian method. Logistic regression analysis was done to test for association of eNOS polymorphisms with susceptibility to renal involvement (microalbuminuria, macroalbuminuria or end-stage renal disease). This analysis was carried out assuming three different genetic models for the minor allele, adjusting for possible effect modifiers.
RESULTS: Genotype and allele frequencies in patients with renal disease were not significantly different from those of patients with normoalbuminuria and healthy blood donors for all eNOS polymorphisms. Likewise, there were no differences in haplotype frequencies among healthy blood donors and type 2 diabetic patients with or without renal involvement (P>0.05 for all comparisons).
CONCLUSION: No associations between the -786T>C, the VNTR intron 4 a/b and the 894G>T (Glu298Asp) polymorphisms in the eNOS gene and renal disease were observed in type 2 diabetic Caucasian-Brazilians.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21255858     DOI: 10.1016/j.diabres.2010.12.029

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  8 in total

1.  eNOS Glu298Asp Polymorphism and Endothelial Dysfunction in Patients with and without End-stage Renal Disease.

Authors:  Nevin İlhan; Kadir Ateş; Necip İlhan; Dilara Kaman; Hüseyin Çeliker
Journal:  Balkan Med J       Date:  2016-03-01       Impact factor: 2.021

2.  NOS3 rs1799983 and rs2070744 polymorphisms and their association with advanced chronic kidney disease and coronary heart disease in Canarian population with type 2 diabetes.

Authors:  M Boronat; A Tugores; P Saavedra; P Garay; E Bosch; D Lorenzo; A Ibarra; C García-Cantón
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Oct-Dec       Impact factor: 1.104

Review 3.  The genetic side of diabetic kidney disease: a review.

Authors:  Jinfang Song; Jiang Ni; Xiaoxing Yin
Journal:  Int Urol Nephrol       Date:  2022-08-16       Impact factor: 2.266

4.  Evaluation of Association Studies and Meta-Analyses of eNOS Polymorphisms in Type 2 Diabetes Mellitus Risk.

Authors:  Di Wang; Liangshu Liu; Chengyu Zhang; Wensheng Lu; Feifei Wu; Xiaofeng He
Journal:  Front Genet       Date:  2022-06-27       Impact factor: 4.772

5.  Association of eNOS and ACE gene polymorphisms as a genetic risk factor in gestational diabetes in Iranian women.

Authors:  Mani Mirfeizi; Mandana Hasanzad; Mahshid Sattari; Mahdi Afshari; Davood Abbasi; Zarin Ajoodani; Ali Bani Sheykheslam
Journal:  J Diabetes Metab Disord       Date:  2018-08-06

Review 6.  Endothelial nitric oxide synthase gene polymorphisms and risk of diabetic nephropathy: a systematic review and meta-analysis.

Authors:  Bruno Schmidt Dellamea; Lana Catani Ferreira Pinto; Cristiane Bauermann Leitão; Katia Gonçalves Santos; Luis Henrique Santos Canani
Journal:  BMC Med Genet       Date:  2014-01-16       Impact factor: 2.103

7.  Association of eNOS and MCP-1 Genetic Variants with Type 2 Diabetes and Diabetic Nephropathy Susceptibility: A Case-Control and Meta-Analysis Study.

Authors:  Priyanka Raina; Ruhi Sikka; Himanshu Gupta; Kawaljit Matharoo; Surinder Kumar Bali; Virinder Singh; Ajs Bhanwer
Journal:  Biochem Genet       Date:  2021-02-20       Impact factor: 1.890

8.  Interaction between the NOS3 gene and obesity as a determinant of risk of type 2 diabetes: the Atherosclerosis Risk in Communities study.

Authors:  Jan Bressler; James S Pankow; Josef Coresh; Eric Boerwinkle
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.